Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination TreatmentBIOMEDICINESIF3.92024-04-301OAAI
Translating precision medicine for autism spectrum disorder: A pressing needDRUG DISCOVERY TODAYIF7.52023-03-013OAAI
Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7BPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12020-12-0712OAAI
Comparing structural and transcriptional drug networks reveals signatures of drug activity and toxicity in transcriptional responsesNPJ SYSTEMS BIOLOGY AND APPLICATIONSIF3.52017-08-2518OAAI
Goblet Cell Hyperplasia Requires High Bicarbonate Transport To Support Mucin ReleaseSCIENTIFIC REPORTSIF3.92016-10-2781OAAI
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channelJOURNAL OF CYSTIC FIBROSISIF62016-07-0112OAAI
Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analoguesBRITISH JOURNAL OF PHARMACOLOGYIF7.72013-08-1537OAAI
Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular FingerprintsJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32012-12-0363PRE
Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonistsJOURNAL OF COMPUTER-AIDED MOLECULAR DESIGNIF3.12012-10-1249PREAI
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonistsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92012-05-0157PREAI